SteinCares and Shilpa Biologicals Enter Strategic Licensing Agreement to Commercialize Biosimilar in Latin America MM Desk 25 February, 2026 SteinCares and Shilpa Biologicals Pvt Ltd have announced a strategic licensing agreement to commercialize a biosimilar therapy across Read More